DANIELL RICHARD (EVP, Europe Commercial) sold 59.2% of their position (140.37K shares) of TEVA PHARMACEUTICAL INDUSTRIES LTD on the open market

Open‑market sale worth $2.22M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 6 sales

DANIELL RICHARD

Filed: 3/6/2025ACC: 0000950170-25-034607

InsiderDANIELL RICHARDCIK 1726096

→

IssuerTEVA PHARMACEUTICAL INDUSTRIES LTDCIK 818686

Officer· EVP, Europe Commercial

Since Mar 2026

-140.37K

Net shares

Net seller

$2.22M

Total sold

Open market trades

0B · 6S

Total transactions

237.14K acquired · 377.51K disposed

Non-Derivative Transactions9

Ordinary Shares

Direct

M · Option Exercise

+33.51K

Price / share

—

Trade value

—

% of position

New position

3/4/2025

0.00→33.51K

Ordinary Shares

Direct

S · Sale

−21.87K

Price / share

$15.73

Trade value

$344.12K

% of position

65.3%

3/4/2025

33.51K→11.64K

Ordinary Shares

Direct

M · Option Exercise

+20.46K

Price / share

—

Trade value

—

% of position

New position

3/4/2025

0.00→20.46K

Ordinary Shares

Direct

S · Sale

−13.35K

Price / share

$15.73

Trade value

$210.10K

% of position

65.3%

3/4/2025

20.46K→7.11K

Ordinary Shares

Direct

M · Option Exercise

+183.17K

Price / share

—

Trade value

—

% of position

New position

3/4/2025

0.00→183.17K

Ordinary Shares

Direct

S · Sale

−56.38K

Price / share

$15.73

Trade value

$887.20K

% of position

30.8%

3/4/2025

183.17K→126.78K

Ordinary Shares

Direct

S · Sale

−11.64K

Price / share

$15.91

Trade value

$185.25K

% of position

New position

3/5/2025

11.64K→0.00

Ordinary Shares

Direct

S · Sale

−7.11K

Price / share

$15.91

Trade value

$113.11K

% of position

New position

3/5/2025

7.11K→0.00

Ordinary Shares

Direct

S · Sale

−30.02K

Price / share

$15.91

Trade value

$477.63K

% of position

23.7%

3/5/2025

126.78K→96.77K

Total

Net shares

+96.77K

Net value

-$2.22M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Ordinary Shares Direct	3/4/2025	M · Option Exercise	+33.51K	—	—	New position	0.00	33.51K
Ordinary Shares Direct	3/4/2025	S · Sale	−21.87K	$15.73	$344.12K	65.3%	33.51K	11.64K
Ordinary Shares Direct	3/4/2025	M · Option Exercise	+20.46K	—	—	New position	0.00	20.46K
Ordinary Shares Direct	3/4/2025	S · Sale	−13.35K	$15.73	$210.10K	65.3%	20.46K	7.11K
Ordinary Shares Direct	3/4/2025	M · Option Exercise	+183.17K	—	—	New position	0.00	183.17K
Ordinary Shares Direct	3/4/2025	S · Sale	−56.38K	$15.73	$887.20K	30.8%	183.17K	126.78K
Ordinary Shares Direct	3/5/2025	S · Sale	−11.64K	$15.91	$185.25K	New position	11.64K	0.00
Ordinary Shares Direct	3/5/2025	S · Sale	−7.11K	$15.91	$113.11K	New position	7.11K	0.00
Ordinary Shares Direct	3/5/2025	S · Sale	−30.02K	$15.91	$477.63K	23.7%	126.78K	96.77K
Total			+96.77K		-$2.22M

Derivative Transactions3

Restricted Share Units

Direct

M · Option Exercise

Converts to

Ordinary Shares

33.51K shares

−33.51K

Strike price

Held after

33.51K

Exercisable

—

3/4/2025

Restricted Share Units

Direct

M · Option Exercise

Converts to

Ordinary Shares

20.46K shares

−20.46K

Strike price

Held after

61.38K

Exercisable

—

3/4/2025

Restricted Share Units

Direct

M · Option Exercise

Converts to

Ordinary Shares

183.17K shares

−183.17K

Strike price

Held after

0.00

Exercisable

—

3/4/2025

Security	Converts To	Date	Type	Shares	Exercisable	Held After
Restricted Share Units Direct	Ordinary Shares33.51K shares	3/4/2025	M · Option Exercise	−33.51K	—	33.51K
Restricted Share Units Direct	Ordinary Shares20.46K shares	3/4/2025	M · Option Exercise	−20.46K	—	61.38K
Restricted Share Units Direct	Ordinary Shares183.17K shares	3/4/2025	M · Option Exercise	−183.17K	—	0.00